{"title":"A second Phase 3 trial affirms efficacy of cytisinicline for smoking cessation","authors":"","doi":"10.1002/pu.31334","DOIUrl":null,"url":null,"abstract":"<p>Smokers receiving the plant-based alkaloid cytisinicline with behavioral support showed significantly higher smoking abstinence rates compared with those receiving placebo with behavioral support, a Phase 3 replication trial has found. The incidence of adverse events was similar between the cytisinicline and placebo groups.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"36 8","pages":"3-4"},"PeriodicalIF":0.0000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Brown University Psychopharmacology Update","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/pu.31334","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Smokers receiving the plant-based alkaloid cytisinicline with behavioral support showed significantly higher smoking abstinence rates compared with those receiving placebo with behavioral support, a Phase 3 replication trial has found. The incidence of adverse events was similar between the cytisinicline and placebo groups.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
